EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
90 hedge funds and large institutions have $196M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-4
Holders Change %
-4.26%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
35
Reduced
26
Closed
13
Calls
$4.08M
Puts
$803K
Net Calls
+$3.28M
Net Calls Change
+$958K
Top Buyers
1 |
Ameriprise
Minneapolis,
Minnesota
|
$47M |
2 |
6CM
683 Capital Management
New York
|
$25.1M |
3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$1.1M |
4 |
Morgan Stanley
New York
|
$985K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$14.4M |